By Stephanie Dalzell - 5 Aug 2021
A 34-year-old woman in New South Wales has died from a rare blood clotting condition, after receiving the AstraZeneca COVID-19 vaccine.
She had received her first dose of the AstraZeneca jab. The Therapeutic Goods Administration (TGA) said the woman died on Wednesday from a confirmed case of thrombosis with thrombocytopenia syndrome (TTS).
"The TGA extends its sincerest condolences to her family and loved ones," the TGA report said.
"We are in close communication with NSW Health, who are undertaking further investigation of this case."
The medical regulator has stressed the protective benefits of vaccination against COVID-19 far outweigh the potential risks.
About 6.8 million doses of AstraZeneca have now been administered across the country, with seven deaths linked to the vaccine.
Six of those deaths were linked to TTS, while the other was a case of immune thrombocytopenia (ITP), which is when your immune system mistakenly attacks and destroys platelets.
Two weeks ago, the nation's expert vaccine advisory group said all adults in Greater Sydney should "strongly consider" getting vaccinated with any available shot, including AstraZeneca.
The medical regulator said in Australia, severe cases of TTS appeared to be more common in women, especially those in younger age groups.
Nearly half of the women with TTS needed intensive care treatment, and five of the six TTS deaths occurred in women.
A 61-year-old woman in Western Australia died in June after taking the AstraZeneca vaccine from another blood clotting condition called immune thrombocytopenic purpura.
------------------
0 Comments